Shares of Chemcon Specialty Chemicals Ltd. ended 72% higher at Rs 584.8 on its trading debut, a week after the company concluded its initial public offering with an overwhelming response.
The stock started trading at Rs 730 apiece, a 115% premium to its issue price of Rs 340, according to data available on the exchanges. The stock rose to as much as Rs 743.8, before paring some of the gains.
The company aims to add new products that will lower the country's reliance on imports, according to Kamal Aggarwal, chairman and managing director at Chemcon Specialty. It is targeting market leadership in new products and whatever markets the firm operates in, he told BloombergQuint in an interview.
This specialty chemical maker's Rs 318-crore IPO was subscribed 149 times on the final day of bidding on Sept. 23. Non-institutional investors made the bulk of the purchases, with the category reserved for them subscribing 450.5 times. Institutional investors followed with 113.4 times bid. The portion for retail portion subscribed 40.4 times.
Chemcon sold 93.5 lakh shares through the offer at Rs 338-340 apiece. It had raised Rs 95.44 crore from anchor investors ahead of its IPO. The specialty chemicals maker intends to use the IPO proceeds as capital expenditure for expanding manufacturing units, working capital and other corporate purposes.
Here are the highlights from the interview:
- Capex cycle expected to get over in next two years
- Have no plans of further expansion beyond the planned capex at the moment
- To become the largest producer of chloromethyl isopropyl carbonate in the world in FY20
- Exploring newer markets for hexamethyldisilazane business
- Expects margins to improve
- Targeting profit after tax to double in next three-four years
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
